In the sale or purchase of a private company its still necessary to use best practices in order to have the parties feel good about the transaction. Using the services of a corporate financial advisor, a tax accountant, a corporate lawyer who work together as a team from the beginning will provide you with the [...]
Vancouver, B.C. based Cardiome Pharma shares skyrocket on a $700 million licensing agreement with Merck based out of Whitestation, New Jersey for Vernakalant, an investigational drug for treatment of atrial ibrillation. The agreement provides Merck with exclusive global rights to the oral formulation of vernakalant (vernakalant [oral]) for maintaining of normal heart rhythm in patients [...]
Polaroid known as a maker of instant cameras and film was finally auctioned off for $59.1 million in a bankrupty protection. This famous company had come upon hard times, but it’s interesting to note that the price tag was for the intellectual property, company, and digital and hard film collection.
Question is that does Patriarch think [...]
Short updates on Life Sciences funding for March 2009.
BiOptix Diagnostics, Inc.: Series A $3M
BiOptix (Boulder, CO) a commercial focused developer of an array-based biomolecule detection system that addresses many markets that currently cannot obtain the needed sensitivity and throughput in a single solution, closed a $3M Series A finacing.
NeoVista, Inc.: [...]
The economy has caused a credit crunch for businesses large and small so the one thing that all businesses should do is to get cozier with your banker. This can take the form of calling more often, visiting, inviting your account manager to your business premises, anything which will provide more real world contact with [...]
People tend to forget that Twitter is 3 years old and that it has tried to figure out the best way to develop its service to reach critical mass and lately to figure out the best way to turn the Web 2.0 service into cold hard cash. I’ve spoken earlier that similar to bricks and [...]
Facebook’s initial failed attempts to takeover Twitter were because the most common reason why mergers & acquisitions fail, VALUATION differences.
